Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
Graziella Pompei, Cardiologist at Romagna Local Health Authority, PHD Student at University of Ferrara, shared on LinkedIn:
”Is aspirin still a valid alternative to clopidogrel in the context of double antithrombotic therapy (antiplatelet plus OAC) in patients requiring chronic OAC undergoing PCI with DES implantation?
Our post-hoc analysis of the PERSEO registry, available online on Journal of Thrombosis and Thrombolysis and presented at the EuroPCR 2026 Congress, aimed to address this question.”
Title: Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry
Authors: Andrea Rubboli, Graziella Pompei, Salvatore De Rosa, Paolo Calabrò, Carolina Moretti, Bernardo Cortese, Mauro Colletta, Vanessa Porretta, Giuseppe Andò, Alessandro Sciahbasi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC